The price-to-earnings ratio for Incyte Corp. (NASDAQ: INCY) is above average at 19.87x, Company’s 36-month beta value is 0.69.Analysts have differing opinions on the stock,
Incyte Corp. (NASDAQ: INCY)’s stock price has decreased by -0.52 compared to its previous closing price of 51.92. However, the company has seen a -2.95%
The stock of Incyte Corp. (INCY) has seen a -3.76% decrease in the past week, with a -8.82% drop in the past month, and a
The stock of Incyte Corp. (INCY) has gone down by -0.95% for the week, with a -7.86% drop in the past month and a -15.98%
Incyte Corp. (NASDAQ: INCY) has a higher price-to-earnings ratio of 21.11x compared to its average ratio, The 36-month beta value for INCY is at 0.67.
© 2024, Powered by Smart TechOne
